TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study

[1]  T. Ottenhoff,et al.  Is there a future for TNF promoter polymorphisms? , 2004, Genes and Immunity.

[2]  R. Mott,et al.  Complex haplotypic structure of the central MHC region flanking TNF in a West African population , 2003, Genes and Immunity.

[3]  Zhi-wei Jiang,et al.  Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. , 2003, The Journal of surgical research.

[4]  G. O’Keefe,et al.  Methodologic quality and genotyping reproducibility in studies of tumor necrosis factor -308 G-->A single nucleotide polymorphism and bacterial sepsis: implications for studies of complex traits. , 2003, Critical care medicine.

[5]  Dominic P. Kwiatkowski,et al.  In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading , 2003, Nature Genetics.

[6]  P. McKeigue,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Problems of Reporting Genetic Associations with Complex Outcomes , 2022 .

[7]  N. Webster,et al.  Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients* , 2003, Critical care medicine.

[8]  D. Crook,et al.  Association of common genetic variant with susceptibility to invasive pneumococcal disease , 2002, BMJ : British Medical Journal.

[9]  K. Welsh,et al.  MBL genotype and risk of invasive pneumococcal disease: a case-control study , 2002, The Lancet.

[10]  A. Cariou,et al.  Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate* , 2002, Critical care medicine.

[11]  J. Lammers,et al.  Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. , 2002, American journal of respiratory and critical care medicine.

[12]  K. Tamura,et al.  Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively , 2002, Immunogenetics.

[13]  T. Horiuchi,et al.  Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. , 2001, Arthritis and rheumatism.

[14]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[15]  J. Vincent,et al.  Association of tumor necrosis factor-2 allele with plasma tumor necrosis factor-alpha levels and mortality from septic shock. , 2001, The American journal of medicine.

[16]  G. Rothe,et al.  Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis , 2001, Critical care medicine.

[17]  J. Rotter,et al.  Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. , 2000, Human molecular genetics.

[18]  C. Chi,et al.  Tumor necrosis factor gene polymorphism and septic shock in surgical infection , 2000, Critical care medicine.

[19]  K. Welsh,et al.  Polymorphic analysis of the high-affinity tumor necrosis factor receptor 2. , 1999, Tissue antigens.

[20]  P. Sham,et al.  Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.

[21]  C. Sprung,et al.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.

[22]  M. Hibberd,et al.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease , 1999, The Lancet.

[23]  J. Dhainaut,et al.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.

[24]  F. Stüber,et al.  Relation of a TNF gene polymorphism to severe sepsis in trauma patients. , 1999, Annals of surgery.

[25]  M. Hibberd,et al.  Mannose-binding lectin and meningococcal disease , 1999, The Lancet.

[26]  K. Tokunaga,et al.  Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. , 1999, Tissue antigens.

[27]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[28]  M. Hibberd,et al.  Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease , 1999, The Lancet.

[29]  D. Bates,et al.  Epidemiology of sepsis syndrome in 8 academic medical centers. , 1997, JAMA.

[30]  K. Welsh,et al.  Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin , 1997 .

[31]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Polman,et al.  TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients , 1997, Journal of Neuroimmunology.

[33]  J. Puyana,et al.  A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality. , 1996, Shock.

[34]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[35]  F. Stüber,et al.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. , 1996, Critical care medicine.

[36]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[37]  François Gouin,et al.  Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .

[38]  W. Buurman,et al.  Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values , 1994, Critical care medicine.

[39]  B. Horsthemke,et al.  A NEW RESTRICTION FRAGMENT LENGTH POLYMORPHISM OF THE HUMAN TNF‐B GENE DETECTED BY Asp HI DIGEST , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[40]  L. Moldawer,et al.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[42]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[43]  P. Suter,et al.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. , 1992, Immunology.

[44]  D. Wallach,et al.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors , 1992, The Journal of experimental medicine.

[45]  E. Girardin,et al.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.

[46]  P. Andersen,et al.  Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.

[47]  H. Orr,et al.  Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. D. Albert,et al.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. , 1987, Surgery, gynecology & obstetrics.

[49]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[50]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[51]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[52]  W. R. Mccabe,et al.  Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients , 1980 .

[53]  A. Forrest,et al.  Letter: Procaine and malignant hyperthermia. , 1974, Lancet.

[54]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .

[55]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[56]  Y. Ohnishi,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2003, Nature Genetics.

[57]  G. Damante,et al.  Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. , 2002, The Journal of rheumatology.

[58]  Dechang Chen,et al.  [Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients]. , 2002, Zhonghua yi xue za zhi.

[59]  G. O’Keefe,et al.  The G-->A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. , 2002, The Journal of trauma.

[60]  指尾 宏子.  Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease,respectively , 2002 .

[61]  R. Cantor,et al.  Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. , 2001, American journal of respiratory and critical care medicine.

[62]  OLAND,et al.  TREATMENT OF SEPTIC SHOCK WITH THE TUMOR NECROSIS FACTOR RECEPTOR : Fc FUSION PROTEIN C , 2000 .

[63]  K. Welsh,et al.  Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. , 1997, Tissue antigens.

[64]  D. Bates,et al.  Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. , 1997, The Journal of infectious diseases.

[65]  I. Udalova,et al.  -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. , 1995, Journal of inflammation.

[66]  B M Brinkman,et al.  Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. , 1995, Journal of inflammation.

[67]  W. R. Mccabe.  Gram-negative bacteremia. , 1973, Disease-a-month : DM.

[68]  L. Cardon,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Population Stratification and Spurious Allelic Association , 2022 .